Practical Dosing Considerations for Venetoclax

20:00 EDT 19 Sep 2019 | Cancer Networks

With FDA-approved indications for both chronic lymphocytic leukemia and acute myeloid leukemia, and continued investigation within multiple disease states, venetoclax has become an exciting oral targeted therapy among oncologists. 

Original Article: Practical Dosing Considerations for Venetoclax


More From BioPortfolio on "Practical Dosing Considerations for Venetoclax"

Quick Search

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...